Genistein, an isoflavone, stimulated the growth of estrogen receptor-positive breast cancer cells implanted in an ovariectomy animal model in a concentration-dependent manner, increasing the cancer risk [38,39]. This evidence concerns the gene ESR1 and breast cancer.